These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 15483669)
1. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction. Okada N; Mori N; Koretomo R; Okada Y; Nakayama T; Yoshie O; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A Gene Ther; 2005 Jan; 12(2):129-39. PubMed ID: 15483669 [TBL] [Abstract][Full Text] [Related]
2. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12. Okada N; Iiyama S; Okada Y; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A Cancer Gene Ther; 2005 Jan; 12(1):72-83. PubMed ID: 15389286 [TBL] [Abstract][Full Text] [Related]
3. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686 [TBL] [Abstract][Full Text] [Related]
4. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity. Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908 [TBL] [Abstract][Full Text] [Related]
5. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
6. Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency. Yoshikawa T; Niwa T; Mizuguchi H; Okada N; Nakagawa S Gene Ther; 2008 Oct; 15(19):1321-9. PubMed ID: 18480845 [TBL] [Abstract][Full Text] [Related]
7. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. Saeki H; Moore AM; Brown MJ; Hwang ST J Immunol; 1999 Mar; 162(5):2472-5. PubMed ID: 10072485 [TBL] [Abstract][Full Text] [Related]
8. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. MartIn-Fontecha A; Sebastiani S; Höpken UE; Uguccioni M; Lipp M; Lanzavecchia A; Sallusto F J Exp Med; 2003 Aug; 198(4):615-21. PubMed ID: 12925677 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin. Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN. Kim JH; Kang TH; Noh KH; Kim SH; Lee YH; Kim KW; Bae HC; Ahn YH; Choi EY; Kim JS; Lee KM; Kim TW Immunol Lett; 2010 Nov; 134(1):47-54. PubMed ID: 20727912 [TBL] [Abstract][Full Text] [Related]